Citadel Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Sell
14,600
-7,200
-33% -$115K ﹤0.01% 11402
2025
Q4
$354K Buy
21,800
+9,800
+82% +$160K ﹤0.01% 9786
2025
Q3
$180K Sell
12,000
-6,000
-33% -$73.1K ﹤0.01% 11374
2025
Q2
$210K Sell
18,000
-9,500
-35% -$86.3K ﹤0.01% 10577
2025
Q1
$204K Buy
27,500
+20,700
+304% +$159K ﹤0.01% 10407
2024
Q4
$40.8K Sell
6,800
-30,900
-82% -$170K ﹤0.01% 12603
2024
Q3
$193K Buy
37,700
+29,300
+349% +$128K ﹤0.01% 10205
2024
Q2
$30.4K Buy
8,400
+5,800
+223% +$18.4K ﹤0.01% 12259
2024
Q1
$8.35K Sell
2,600
-36,700
-93% -$142K ﹤0.01% 13562
2023
Q4
$193K Buy
39,300
+21,900
+126% +$99.9K ﹤0.01% 10014
2023
Q3
$94.8K Sell
17,400
-4,700
-21% -$31.1K ﹤0.01% 10965
2023
Q2
$148K Sell
22,100
-7,500
-25% -$55.8K ﹤0.01% 10358
2023
Q1
$261K Sell
29,600
-15,600
-35% -$138K ﹤0.01% 9669
2022
Q4
$345K Buy
45,200
+23,000
+104% +$179K ﹤0.01% 9006
2022
Q3
$158K Sell
22,200
-5,200
-19% -$49K ﹤0.01% 10651
2022
Q2
$222K Sell
27,400
-17,300
-39% -$152K ﹤0.01% 10475
2022
Q1
$620K Buy
44,700
+16,500
+59% +$259K ﹤0.01% 8874
2021
Q4
$791K Sell
28,200
-27,400
-49% -$840K ﹤0.01% 8518
2021
Q3
$1.89M Sell
55,600
-129,700
-70% -$4.69M ﹤0.01% 6504
2021
Q2
$7.57M Sell
185,300
-80,400
-30% -$3.13M 0.01% 3593
2021
Q1
$10.7M Buy
265,700
+191,200
+257% +$10.3M 0.01% 2868
2020
Q4
$4.41M Buy
74,500
+20,300
+37% +$1.05M ﹤0.01% 3892
2020
Q3
$2.64M Buy
54,200
+20,000
+58% +$841K ﹤0.01% 4211
2020
Q2
$1.66M Sell
34,200
-1,100
-3% -$40.1K ﹤0.01% 4902
2020
Q1
$981K Buy
35,300
+19,500
+123% +$544K ﹤0.01% 5368
2019
Q4
$473K Sell
15,800
-9,500
-38% -$273K ﹤0.01% 6904
2019
Q3
$782K Buy
+25,300
New +$1.03M ﹤0.01% 6013

Other funds holding ADPT